NDC 55154-6931

ONGLYZA

Saxagliptin

ONGLYZA is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Cardinal Health 107, Llc. The primary component is Saxagliptin Hydrochloride.

Product ID55154-6931_048ab1ca-6e74-49ad-9a9e-c866a2b9ce01
NDC55154-6931
Product TypeHuman Prescription Drug
Proprietary NameONGLYZA
Generic NameSaxagliptin
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2014-11-20
Marketing CategoryNDA / NDA
Application NumberNDA022350
Labeler NameCardinal Health 107, LLC
Substance NameSAXAGLIPTIN HYDROCHLORIDE
Active Ingredient Strength5 mg/1
Pharm ClassesDipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 55154-6931-2

1080 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55154-6931-2)
Marketing Start Date2014-11-20
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 55154-6931-2 [55154693102]

ONGLYZA TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA022350
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-11-20

NDC 55154-6931-8 [55154693108]

ONGLYZA TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA022350
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-11-20
Marketing End Date2018-02-28

Drug Details

Active Ingredients

IngredientStrength
SAXAGLIPTIN HYDROCHLORIDE5 mg/1

OpenFDA Data

SPL SET ID:e4f2a84f-5117-4738-b769-aba8debbddb0
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 858036
  • 858040
  • UPC Code
  • 0355154693128
  • Pharmacological Class

    • Dipeptidyl Peptidase 4 Inhibitor [EPC]
    • Dipeptidyl Peptidase 4 Inhibitors [MoA]

    NDC Crossover Matching brand name "ONGLYZA" or generic name "Saxagliptin"

    NDCBrand NameGeneric Name
    0310-6100ONGLYZASAXAGLIPTIN
    0310-6105ONGLYZASAXAGLIPTIN
    55154-6931ONGLYZASAXAGLIPTIN

    Trademark Results [ONGLYZA]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ONGLYZA
    ONGLYZA
    85504669 not registered Dead/Abandoned
    Bristol-Myers Squibb Company
    2011-12-28
    ONGLYZA
    ONGLYZA
    85162195 3970694 Dead/Cancelled
    ASTRAZENECA AB
    2010-10-27
    ONGLYZA
    ONGLYZA
    78791308 3723838 Live/Registered
    ASTRAZENECA AB
    2006-01-13
    ONGLYZA
    ONGLYZA
    77871907 not registered Dead/Abandoned
    Bristol-Myers Squibb Company
    2009-11-13
    ONGLYZA
    ONGLYZA
    77798656 not registered Dead/Abandoned
    ASTRAZENECA AB
    2009-08-06
    ONGLYZA
    ONGLYZA
    77769979 not registered Dead/Abandoned
    Bristol-Myers Squibb Company
    2009-06-29
    ONGLYZA
    ONGLYZA
    77769972 not registered Dead/Abandoned
    Bristol-Myers Squibb Company
    2009-06-29
    ONGLYZA
    ONGLYZA
    77411067 not registered Dead/Abandoned
    Bristol-Myers Squibb Company
    2008-03-03
    ONGLYZA
    ONGLYZA
    77394393 not registered Dead/Abandoned
    Bristol-Myers Squibb Company
    2008-02-12
    ONGLYZA
    ONGLYZA
    77394390 not registered Dead/Abandoned
    Bristol-Myers Squibb Company
    2008-02-12
    ONGLYZA
    ONGLYZA
    77342421 not registered Dead/Abandoned
    Bristol-Myers Squibb Company
    2007-12-03
    ONGLYZA
    ONGLYZA
    77342416 not registered Dead/Abandoned
    Bristol-Myers Squibb Company
    2007-12-03

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.